Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico

Por: Munoz-Torrico M., Salazar M.A., Millán M.D.J.M., Orozco J.A.M., Diaz L.A.N., Del Pilar M.S., Visca D., D'Ambrosio L., Centis R., Migliori G.B.

---

Publicada: 1 ene 2018

---

---

Filiaciones:
Munoz-Torrico M.:
 Tuberculosis Clinic, National Institute of Respiratory Diseases of Mexico (INER), Mexico City, Mexico

Salazar M.A.:
 Tuberculosis Clinic, National Institute of Respiratory Diseases of Mexico (INER), Mexico City, Mexico

Millán M.D.J.M.:
 Tuberculosis Clinic, National Institute of Respiratory Diseases of Mexico (INER), Mexico City, Mexico

Orozco J.A.M.:
 Clinical Microbiology Laboratory, INER, Mexico City, Mexico

Diaz L.A.N.:
 Clinical Microbiology Laboratory, INER, Mexico City, Mexico

Del Pilar M.S.:
 Clinical Microbiology Laboratory, INER, Mexico City, Mexico

Visca D.:
 Pneumology Unit, Maugeri Care and Research Institute, IRCCS, Tradate, Italy

D'Ambrosio L.:
 World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Fondazione S. Maugeri, Care and Research Institute, via Roncaccio 16, Tradate, 21049, Italy

 Public Health Consulting Group, Lugano, Switzerland

Centis R.:
 World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Fondazione S. Maugeri, Care and Research Institute, via Roncaccio 16, Tradate, 21049, Italy

Migliori G.B.:
 World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Fondazione S. Maugeri, Care and Research Institute, via Roncaccio 16, Tradate, 21049, Italy